Global Natural Polymer Market — South Africa by Application

### Identity and listing | Field | Detail | |---|---| | Entity profiled | Eastman Chemical Company (exact legal-name match; active; publicly listed) | | Listing status vs. input list | Confirmed public company — matches the type supplied | | Former names / predecessors | Tennessee Eastman Company / Corporation (Kodak's chemical subsidiary, founded 1920); Eastman Chemical Products (marketing arm); operated as Eastman Kodak's chemicals division until spin-off | | Founding year | 1920 (Kingsport, Tennessee, by George Eastman) | | Incorporation | Delaware, 1993 (2026 Proxy, "Eastman at a Glance") | | Spin-off from Eastman Kodak | Effective 31 Dec 1993; NYSE trading from early January 1994 | | Headquarters | 200 South Wilcox Drive, Kingsport, Tennessee 37660, USA | | Exchange / ticker | New York Stock Exchange: EMN | | ISIN / CUSIP | US2774321002 / 277432100 (standard identifiers; not re-checked against filing cover page) | | Fiscal year end | 31 December | | Auditor | PricewaterhouseCoopers LLP (ratified for FY2026 at 7 May 2026 AGM; lead partner rotated in 2026) | | Website | www.eastman.com | | Market capitalization | USD 7.39 billion (5 Oct 2026, share price USD 64.62; 114.33 million shares) | | Enterprise value | USD 12.16 billion (S&P Global via StockAnalysis, 5 Oct 2026) | | Credit ratings | Moody's Baa2 (outlook negative, changed ~Aug 2026); S&P BBB (outlook negative since Aug 2025, affirmed Nov 2025); Fitch: BBB historically (current outlook n/v) | | CEO & Board Chair | Mark J. Costa (CEO since January 2014) | | Customers served | More than 100 countries | | Metric | FY2023 | FY2024 | FY2025 | |---|---|---|---| | Employees (approx., headcount) | 14000 | 14000 | 13000 | Sources: FY2024 headcount from company boilerplate in August 2025 releases ("approximately 14,000"); FY2025/2026 from FY2025 results release and 2026 Proxy ("approximately 13,000"). The roughly 7% reduction between 2024 and 2025 aligns with corporate severance charges of USD 34 million booked in FY2025 (FY2025 financial tables, Table 3A note 7). Eastman is a ~USD 8.8 billion, Kingsport-headquartered specialty materials producer whose competitive identity rests on deeply integrated, largely U.S.-based asset complexes in Tennessee and Texas that convert coal-derived syngas, cellulose, propane and—increasingly—waste plastic into higher-value polymers, films, additives and fibers. Roughly two-thirds of revenue comes from two specialty segments (Advanced Materials and Additives & Functional Products) anchored by franchise brands such as Saflex interlayers, LLumar window films, Tritan copolyester, Therminol heat-transfer fluids and Naia textiles. The remaining third—Chemical Intermediates and Fibers—supplies scale, integration economics and cash but carries commodity cyclicality and structural decline risk (acetate tow). Management's differentiator is an "innovation-driven growth model" layered with a circular-economy platform (Kingsport methanolysis molecular recycling). The investment debate centres on whether innovation and circularity can outrun cyclical demand, an elevated 3x+ leverage profile, and a decade of flat-to-declining revenue. --- ### Company's own description (paraphrased from FY2025 releases and 2026 Proxy) Eastman describes itself as a global specialty materials company that produces a broad range of products found in everyday items, with a stated purpose of enhancing the quality of life in a material way. It attributes its growth to an innovation-driven model built on world-class technology platforms, deep customer engagement and differentiated application development, which it uses to grow leading positions in attractive end markets—explicitly naming transportation, building and construction, and consumables. The 2026 Proxy adds that its strategy is founded on innovating sustainable solutions and maintaining its social license to operate, framed around a "triple challenge" of carbon neutrality, circularity and caring for society. ### Independent characterization Eastman is best understood as a hybrid specialty/intermediates producer whose specialty franchises sit on top of integrated commodity-like streams. Four integrated technology streams underpin the portfolio: 1. **Acetyl/cellulosics stream (Kingsport):** coal gasification produces syngas → methanol → acetic acid/acetic anhydride; combined with wood pulp to make cellulose esters (cellulose acetate flake, CAB, CAP). Outputs feed acetate tow and textile yarn (Fibers), cellulose-ester coatings additives (AFP), and cellulose-based plastics (AM). 2. **Polyester/copolyester stream (Kingsport):** proprietary monomers (e.g., CHDM, TMCD) enable Tritan and Eastar copolyesters; the methanolysis molecular-recycling unit depolymerizes polyester waste back into monomers that substitute for virgin feedstock. 3. **Olefins/oxo stream (Longview, Texas — second-largest site):** propane/ethane cracking → propylene/ethylene → oxo alcohols, plasticizers, glycol ethers and solvents (Chemical Intermediates), plus feedstock for specialty additives. 4. **Alkylamines and specialty fluids (Taminco/Solutia heritage):** methylamines, ethylamines and higher amines for agriculture, water treatment, personal care and pharma; Therminol heat-transfer fluids and Skydrol aviation hydraulic fluids. ### Revenue model | Revenue type | Share of revenue | Comment | |---|---|---| | Product sales (B2B) | ~99%+ | Essentially all revenue is from manufactured-product sales under spot, contract and cost-pass-through arrangements | | Technology licensing | Not separately disclosed (immaterial) | Oxo process technology licensing; APAC licensing programs were discontinued in 4Q2025 (USD 13 million adjustment in CI segment) | | Services / subscription | None material | Technical service is bundled with product sales | Pricing mechanisms (FY2025 releases): AFP uses cost-pass-through contracts for a meaningful share of volume (price +3% in FY2025 explicitly attributed to them); Fibers acetate tow is sold under annual contracts with minimum commitments (2Q2026 call: tow volumes rise in 2H as customers meet annual minimums); CI is spread-driven against propane/ethylene and Asian competition; AM is value-priced (management "defended price" in 4Q2025 despite volume declines). ### Value-chain position Eastman sits in the mid-stream to downstream of the chemical value chain: it is backward-integrated into basic feedstocks (syngas, olefins) but sells primarily to converters and OEM tier suppliers—windshield laminators, film converters/installers, plastic molders, coatings formulators, agrochemical formulators, cigarette-filter makers and textile mills—rather than to consumers. Brand recognition at consumer level exists for a few franchises (LLumar films, Tritan in drinkware, Naia in apparel), which supports co-branding and pricing. ### Customer types and end markets The 2026 Proxy lists FY2025 revenue by end-use market across: Transportation; Building and Construction; Consumables; Durables and Electronics; Personal Care and Wellness; Filter Media; Medical and Pharma; Industrial Chemicals; Food, Feed and Agriculture; Water Treatment and Energy; and Other Markets. The proxy states 56% of revenue arises outside North America (FY2025). Customer concentration: no single customer is disclosed as ≥10% of sales in sources reviewed (n/v).

Nouryon is a carve-out specialty chemicals platform built from the former specialty chemicals arm of AkzoNobel and owned since 2018 by Carlyle and GIC. It manufactures performance ingredients and process chemicals — surfactants, chelates, cellulose ethers, organic peroxides, metal alkyls, colloidal silica, expandable microspheres, chromatography media and pulp-bleaching chemicals — that customers use to make consumer and industrial products. Revenue is roughly $5.1bn, generated through roughly 63 plants and sold in more than 80 countries. Its competitive identity rests on a portfolio of global or regional leadership positions in niche, technically demanding chemistries (Expancel®, Kromasil®, Levasil®, Bermocoll®, Dissolvine®), long-term integrated supply contracts with pulp mills, and a disciplined, Axalta-style private-equity operating model under CEO Charlie Shaver. The investment debate centres on high adjusted EBITDA margins (~22.5%) and solid free cash flow set against heavy leverage (~5.0x), recurring IPO deferrals and cyclic exposure to polymer and pulp markets. --- ### What the company does Nouryon produces specialty and performance chemicals that enter customer formulations or manufacturing processes as functional ingredients, catalysts, initiators or process aids. The company itself characterises its output as "essential solutions" that customers use to manufacture everyday products in attractive end-markets, and it describes the business in its fact sheet as a global specialty chemicals leader operating in more than 80 countries with a portfolio of industry-leading brands (Nouryon company fact sheet). In its 2025 sustainability report the company frames growth as coming from innovating safer, more efficient and more sustainable chemistry for customers (Nouryon 2025 Sustainability Report release, 7 May 2026). ### Company's own description (paraphrased from latest public materials) Nouryon presents itself as a global specialty chemicals leader whose products are used in personal care, cleaning goods, paints and coatings, agriculture and food, pharmaceuticals, building products, polymers, pulp and paper, oil and gas, and mining. Since the Q3 2024 reorganisation it organises around three segments — Consumer & Life Sciences, Performance Materials and Resource Solutions — and six business units (FY2024 results release, 7 Mar 2025). ### Independent characterisation Nouryon is best understood as a portfolio of ~30–40 mid-sized niche chemistry franchises sharing a common manufacturing, procurement and commercial backbone. Roughly three economic archetypes coexist: 1. **Formulated consumer ingredients** (surfactants, chelates, cellulose ethers, polymers for home & personal care, agro adjuvants, micronutrients): moderate cyclicality, sticky qualification, pricing tied to raw materials (ethylene oxide, fatty amines, cellulose). 2. **Polymer process chemistry** (organic peroxides, metal alkyls, PVC reactor additives): technically demanding, hazardous-materials handling acts as a barrier to entry; volumes track polyolefin and PVC operating rates, notably in China. 3. **Resource / pulp chemistry** (sodium chlorate, chlorine dioxide, hydrogen peroxide, mining and oilfield chemicals): energy-intensive and contract-based, with 10–15-year integrated "chemical island" supply agreements for pulp mills, especially in South America. ### Business and revenue model | Revenue model element | Estimated share | Comment | |---|---|---| | Product sales (B2B chemicals, spot + contract) | ~95%+ | Core model; priced per tonne, often with raw-material pass-through clauses | | Long-term integrated supply (pulp-mill "Integrated Manufacturing Model") | n/d (embedded in Resource Solutions) | 10–15-year agreements, e.g., Suzano (15-year, 2022), Metsä Fibre (2021), Arauco MAPA (2023), Bracell (2021) | | Technology licensing | Small, n/d | e.g., CiD PVC technology license in China (Jul 2021); SulNOx fuel additive licensing (trade press) | | Services / subscription | Negligible | Digital tools (My Nouryon portal; BeautyCreations™ AI formulation tool) support sales but are not separately monetised (n/d) | ### Value chain position Nouryon sits mid-stream: it buys base chemicals and energy (ethylene, ethylene oxide, fatty raw materials, salt/chlor-alkali derivatives — some from sister company Nobian — cellulose, aluminium, electricity), converts them into functional intermediates, and sells to formulators and manufacturers (consumer goods companies, paint makers, polymer producers, pulp mills, agrochemical formulators, pharma manufacturers). Distribution partners include IMCD and Brenntag Specialties for selected regions and lines. ### Customer types and end-markets | End-market cluster | Representative products | Representative named customers/partners (public) | |---|---|---| | Home & personal care | Surfactants, chelates (Dissolvine®), polymers, CMC, Structure® starches, Armocare® | Henkel Consumer Brands (2025 sustainability award) | | Agriculture & food | Adjuvants (Adsee®), micronutrients (HBED, EDDHA), ADOB fertilizers, food-grade ingredients | n/d | | Pharma & life sciences | Kromasil® chromatography media (peptide/GLP-1 purification) | n/d | | Paints, coatings & inks | Bermocoll® cellulose ethers, Expancel® microspheres, rheology modifiers | n/d | | Polymers | Organic peroxides, metal alkyls (TEAL, MMAO), PVC additives, recycled-PP restoration | Petro Rabigh (2024 supplier award) | | Pulp, paper & packaging | Sodium chlorate, chlorine dioxide plants, hydrogen peroxide, Expancel® for paperboard | Suzano, Arauco, Metsä Fibre, Bracell | | Oil, gas & mining | Demulsifiers, collectors, oilfield surfactants | n/d | | Building & infrastructure | Asphalt additives, cellulose ethers, colloidal silica | Brenntag (US asphalt distribution) | | Electronics, catalysts, batteries | Levasil® colloidal silica, high-purity metalorganics | n/d |

Company Headquarters: Texas, U.S. Founded: 1882 Workforce: ~9,900 Company Working: Darling Ingredients Inc. (Darling Ingredients) is a global company involved in the manufacturing and development of sustainable natural ingredients. The company’s product segments include food ingredients, feed ingredients, and fuel ingredients for a plethora of end-use industries comprising food (including pet food), animal feed, pharmaceuticals, personal care products, fertilizer, leather goods, fuel, and bioenergy. The company’s major product types comprise fats, proteins, bakery, used cooking oil, bioenergy, and biofuels, among others. In addition, it is also involved in environmental services including waste disposal of food service stores like restaurants, grocery stores, and supermarkets. Gelatin products of the company are marketed under its health brand Rousselot and are manufactured in the eleven production plants. The consumer base of the brand is spread across 75 countries with six sales locations. The key-end use industries of Rouseelot’s gelatin include food, pharma, and other technical applications. The recent acquisition of Gelnex strengthens the gelatin product portfolio of the company. Gelnex (Brazil) is one of the leading gelatin and collagen manufacturer in South America and has six production sites operated with a workforce of 1,000 employees

Company Headquarters: Lestrem, France Founded: 1933 Workforce: ~8,360 Company Working: Roquette Frères is a family-owned business, with leadership in plant-based ingredients across the globe. The company has got expertise in plant-based proteins and is also a foremost provider of excipients for pharmaceutical products. Roquette Frères currently runs its business in more than 100 nations, across the globe, and has a skilled workforce who works continuously to achieve the goals and missions of the company. The company focused its business on “Life and nature”. The raw materials offered by the company are sourced naturally. The company has a diversified range of plant protein portfolio; it offers various solutions for the pharmaceutical industry that has a major role in bio-medical treatments. Moreover, the company also develops novel ingredients for the food, health, and nutrition industry. Roquette Frères reveals the ability of nature to enhance, save lives, and cure individuals. The company produces wheat starch and gluten in Lithuania, it also offers starches from various raw materials such as maize, potatoes, waxy maize, peas, and tapioca, along with wheat glucose syrups food and beverage industry. Moreover, the protein-enriched products obtained during the production process have diversified applications in animal feed. The company has a presence in North America, Europe, and Asia-Oceania.

Daicel is a mid-cap Japanese diversified specialty-chemicals group. Its roots are in cellulose chemistry, and it has evolved into five businesses built on four technology platforms: cellulose and acetyl chemistry, organic synthesis, polymer science, and pyrotechnics. It is Japan's only producer of acetic acid. That position anchors a vertically integrated acetyl chain running from methanol and carbon monoxide through acetic anhydride and cellulose acetate to acetate tow for cigarette filters, a global oligopoly product in which Daicel is a top-tier supplier. Through Polyplastics, which became wholly owned in 2020 and was absorbed into the parent on 1 April 2026, Daicel is a leading global supplier of polyacetal (POM), PBT, LCP and COC engineering plastics. It is also a major independent maker of automotive airbag inflators and a world leader in chiral separation columns. Its investment case currently turns on whether the ¥115–160 billion growth-capex cycle converts into earnings under the "Accelerate 2030" plan. Headcount has been essentially flat across the three-year trend, from 11,134 in FY2024 to 11,034 in FY2026 (−0.9%). Over the same period the group integrated Toyama Filter Tow and exited several sub-scale businesses. --- ### Company's own description (Yuho FY2026/3, paraphrased) The Yuho describes the group's main activity as the manufacture and sale of products in five domains: Medical/Healthcare, Smart, Safety, Materials and Engineering Plastics. A small "Other" segment covers water-treatment membranes and group logistics. The roles of the main operating entities are as follows: **Daicel Corporation (parent):** makes and sells health foods, chiral columns, caprolactone derivatives, epoxy compounds, electronic-materials chemicals, high-performance films, acetate tow, cellulose acetate, acetic-acid derivatives and cosmetic ingredients. **Kyodo Acetic Acid:** (92% owned) converts carbon monoxide and methanol supplied by Daicel into acetic acid. **Daicel Safety Systems:** and its overseas affiliates in the USA, Thailand, Poland, China and India make airbag inflators and initiators. **Polyplastics:** and its overseas affiliates made POM, PBT and LCP until the April 2026 split. Its operating business now sits inside the parent as the High Performance Polymers SBU. **Daicel Miraizu:** sells water-soluble polymers, packaging films and AS resin. The company describes itself as organized around Strategic Business Units (SBUs). Each SBU sets a comprehensive domestic and overseas strategy. ### Business model and revenue model Daicel's revenue is almost entirely product revenue from manufactured chemicals, polymers and devices sold under contract or spot terms. It has no material subscription, licensing or service revenue at group level. There are some service-like activities. Chiral Technologies offers contract chiral separation services. Polyplastics/HPP provides technical-solution services through overseas Technical Solution Centers, bundled into resin pricing. Daicel also licenses inflator technology internally to its Safety subsidiaries. None of these is disclosed as a separate revenue stream. Pricing is a mix of: 1. **Long-term contracts** for acetate tow with major tobacco companies. The 1H FY2026/3 presentation said these contracts were progressing as planned with stable prices. 2. **Formula or market-linked pricing** for acetic acid and derivatives, exposed to methanol and Asian acetic-acid spot spreads. 3. **Program-based pricing** for airbag inflators, awarded per vehicle platform, with volume tied to automotive production. 4. **Specification-driven, technical-service-intensive pricing** for engineering plastics and semiconductor materials. ### Value-chain position Daicel is unusually integrated for a company of its size. In the acetyl chain it is upstream: it makes CO from coal and coke at Aboshi, buys methanol, and makes acetic acid via Kyodo Acetic Acid. It is also midstream (acetic anhydride, cellulose acetate) and downstream (acetate tow, TAC film flake, cosmetic 1,3-BG). In engineering plastics it is a monomer-to-compound resin producer: it supplies acetic anhydride internally for LCP and makes POM from methanol-derived formaldehyde. In Safety it is a Tier-2 supplier: it sells inflators and initiators to airbag module makers (Tier-1s), who in turn supply automakers. ### Customer types and end-markets | End-market | Segments serving it | Representative customers (type) | |---|---|---| | Tobacco (combustible and heated) | Materials (acetate tow) | Global and Chinese tobacco manufacturers | | Automotive | High Performance Polymers, Safety | Tier-1 airbag module makers; auto-parts molders; OEMs | | Electronics and semiconductors | Smart, HPP (LCP for AI servers), Materials (TAC for LCD) | Photoresist makers, semiconductor fabs, display film makers, connector makers | | Pharmaceuticals and life sciences | Life Science (formerly Medical/Healthcare) | Pharma R&D and process chemistry groups, CDMOs | | Consumer health and cosmetics | Materials (Cosme, 1,3-BG), Life Science (health food ingredients) | Cosmetic formulators, supplement brands | | Chemicals (vinyl acetate, PTA) | Materials (acetic acid) | Japanese and Asian chemical producers | | Packaging | HPP (TOPAS COC), Materials/Miraizu (barrier films) | Film converters, medical packaging | | Water treatment | Life Science (membranes, reclassified in FY2027/3) | Municipal and industrial water | ### Independent characterization Daicel is best understood as two large, cash-generative but cyclical franchises subsidizing a set of smaller growth options. The franchises are the acetyl/acetate tow chain and Polyplastics-derived engineering plastics. In FY2026/3 they produced ¥34.1 billion of the ¥42.1 billion of segment operating profit (81%). Safety is a scale business with thin margins (5.9% in FY2026/3) that is only now recovering. Smart and Life Science together contributed less than ¥1 billion of operating profit in FY2026/3 on ¥54 billion of sales. Management has publicly acknowledged two problems. The first is a low P/E. The second is an earnings structure over-dependent on certain products, while intended new earnings pillars struggled to grow (President's message, Daicel Report 2025). The 2026 reorganization was designed to address both. It folded Polyplastics into the parent, renamed segments, and moved Cosme and Miraizu into Materials.